Literature DB >> 33556408

The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins.

Kristina V Tugaeva1, Dorothy E D P Hawkins2, Jake L R Smith2, Oliver W Bayfield2, De-Sheng Ker2, Andrey A Sysoev1, Oleg I Klychnikov3, Alfred A Antson4, Nikolai N Sluchanko5.   

Abstract

The coronavirus nucleocapsid protein (N) controls viral genome packaging and contains numerous phosphorylation sites located within unstructured regions. Binding of phosphorylated SARS-CoV N to the host 14-3-3 protein in the cytoplasm was reported to regulate nucleocytoplasmic N shuttling. All seven isoforms of the human 14-3-3 are abundantly present in tissues vulnerable to SARS-CoV-2, where N can constitute up to ~1% of expressed proteins during infection. Although the association between 14-3-3 and SARS-CoV-2 N proteins can represent one of the key host-pathogen interactions, its molecular mechanism and the specific critical phosphosites are unknown. Here, we show that phosphorylated SARS-CoV-2 N protein (pN) dimers, reconstituted via bacterial co-expression with protein kinase A, directly associate, in a phosphorylation-dependent manner, with the dimeric 14-3-3 protein, but not with its monomeric mutant. We demonstrate that pN is recognized by all seven human 14-3-3 isoforms with various efficiencies and deduce the apparent KD to selected isoforms, showing that these are in a low micromolar range. Serial truncations pinpointed a critical phosphorylation site to Ser197, which is conserved among related zoonotic coronaviruses and located within the functionally important, SR-rich region of N. The relatively tight 14-3-3/pN association could regulate nucleocytoplasmic shuttling and other functions of N via occlusion of the SR-rich region, and could also hijack cellular pathways by 14-3-3 sequestration. As such, the assembly may represent a valuable target for therapeutic intervention.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  host-pathogen interactions; nucleocytoplasmic shuttling; phosphorylation; protein–protein complex; stoichiometry

Mesh:

Substances:

Year:  2021        PMID: 33556408      PMCID: PMC7863765          DOI: 10.1016/j.jmb.2021.166875

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  81 in total

Review 1.  C-terminal binding: an expanded repertoire and function of 14-3-3 proteins.

Authors:  Brian Coblitz; Meng Wu; Sojin Shikano; Min Li
Journal:  FEBS Lett       Date:  2006-02-17       Impact factor: 4.124

2.  Reading the phosphorylation code: binding of the 14-3-3 protein to multivalent client phosphoproteins.

Authors:  Nikolai N Sluchanko
Journal:  Biochem J       Date:  2020-04-17       Impact factor: 3.857

3.  N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation.

Authors:  Brandon E Aubol; Ryan M Plocinik; Malik M Keshwani; Maria L McGlone; Jonathan C Hagopian; Gourisankar Ghosh; Xiang-Dong Fu; Joseph A Adams
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

4.  SARS-CoV-2: Zoonotic origin of pandemic coronavirus.

Authors:  S Vilcek
Journal:  Acta Virol       Date:  2020       Impact factor: 1.162

5.  The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication.

Authors:  Shaun Tylor; Anton Andonov; Todd Cutts; Jingxin Cao; Elsey Grudesky; Gary Van Domselaar; Xuguang Li; Runtao He
Journal:  Can J Microbiol       Date:  2009-03       Impact factor: 2.419

Review 6.  Phase separation in biology; functional organization of a higher order.

Authors:  Diana M Mitrea; Richard W Kriwacki
Journal:  Cell Commun Signal       Date:  2016-01-05       Impact factor: 5.712

7.  Three Emerging Coronaviruses in Two Decades.

Authors:  Jeannette Guarner
Journal:  Am J Clin Pathol       Date:  2020-03-09       Impact factor: 2.493

8.  Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.

Authors:  Christiane Iserman; Christine A Roden; Mark A Boerneke; Rachel S G Sealfon; Grace A McLaughlin; Irwin Jungreis; Ethan J Fritch; Yixuan J Hou; Joanne Ekena; Chase A Weidmann; Chandra L Theesfeld; Manolis Kellis; Olga G Troyanskaya; Ralph S Baric; Timothy P Sheahan; Kevin M Weeks; Amy S Gladfelter
Journal:  Mol Cell       Date:  2020-11-27       Impact factor: 17.970

Review 9.  Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

Authors:  Anil Kumar Rana; Shubham Nilkanth Rahmatkar; Amit Kumar; Damanpreet Singh
Journal:  Cytokine Growth Factor Rev       Date:  2020-08-25       Impact factor: 7.638

10.  Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.

Authors:  Christopher R Carlson; Jonathan B Asfaha; Chloe M Ghent; Conor J Howard; Nairi Hartooni; Maliheh Safari; Alan D Frankel; David O Morgan
Journal:  Mol Cell       Date:  2020-11-20       Impact factor: 17.970

View more
  20 in total

1.  Plasticity in structure and assembly of SARS-CoV-2 nucleocapsid protein.

Authors:  Huaying Zhao; Ai Nguyen; Di Wu; Yan Li; Sergio A Hassan; Jiji Chen; Hari Shroff; Grzegorz Piszczek; Peter Schuck
Journal:  PNAS Nexus       Date:  2022-05-16

Review 2.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 3.  The role of 14-3-3 proteins in cell signalling pathways and virus infection.

Authors:  Jiaqi Liu; Shengliang Cao; Guofei Ding; Bin Wang; Yingchao Li; Yuzhong Zhao; Qingyuan Shao; Jian Feng; Sidang Liu; Liting Qin; Yihong Xiao
Journal:  J Cell Mol Med       Date:  2021-04-01       Impact factor: 5.310

Review 4.  Dynamic, but Not Necessarily Disordered, Human-Virus Interactions Mediated through SLiMs in Viral Proteins.

Authors:  Heidy Elkhaligy; Christian A Balbin; Jessica L Gonzalez; Teresa Liberatore; Jessica Siltberg-Liberles
Journal:  Viruses       Date:  2021-11-26       Impact factor: 5.048

5.  Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture.

Authors:  Denis E Kolesov; Maria V Sinegubova; Irina V Safenkova; Ivan I Vorobiev; Nadezhda A Orlova
Journal:  PeerJ       Date:  2022-01-07       Impact factor: 2.984

6.  Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.

Authors:  Bryan A Johnson; Yiyang Zhou; Kumari G Lokugamage; Michelle N Vu; Nathen Bopp; Patricia A Crocquet-Valdes; Birte Kalveram; Craig Schindewolf; Yang Liu; Dionna Scharton; Jessica A Plante; Xuping Xie; Patricia Aguilar; Scott C Weaver; Pei-Yong Shi; David H Walker; Andrew L Routh; Kenneth S Plante; Vineet D Menachery
Journal:  bioRxiv       Date:  2022-03-28

7.  Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins.

Authors:  Samanta Del Veliz; Lautaro Rivera; Diego M Bustos; Marina Uhart
Journal:  Biochem Biophys Res Commun       Date:  2021-07-02       Impact factor: 3.575

8.  p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein.

Authors:  Athanasios Panagiotopoulos; Melpomeni Tseliou; Ioannis Karakasiliotis; Danai-Maria Kotzampasi; Vangelis Daskalakis; Nikolaos Kesesidis; George Notas; Christos Lionis; Marilena Kampa; Stergios Pirintsos; George Sourvinos; Elias Castanas
Journal:  Pharmacol Res Perspect       Date:  2021-08

9.  In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19.

Authors:  Athene Hoi-Ying Lam; Jian-Piao Cai; Ka-Yi Leung; Ricky-Ruiqi Zhang; Danlei Liu; Yujing Fan; Anthony Raymond Tam; Vincent Chi-Chung Cheng; Kelvin Kai-Wang To; Kwok-Yung Yuen; Ivan Fan-Ngai Hung; Kwok-Hung Chan
Journal:  Diagnostics (Basel)       Date:  2021-12-13

10.  Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.

Authors:  David Hodgson; Hayley Colton; Hailey Hornsby; Rebecca Brown; Joanne Mckenzie; Kirsty L Bradley; Cameron James; Benjamin B Lindsey; Sarah Birch; Louise Marsh; Steven Wood; Martin Bayley; Gary Dickson; David C James; Martin J H Nicklin; Jon R Sayers; Domen Zafred; Sarah L Rowland-Jones; Goura Kudesia; Adam Kucharski; Thomas C Darton; Thushan I de Silva; Paul J Collini
Journal:  medRxiv       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.